Globant Enterprise AI Powers Next Wave of Business AI, Incorporating MCP and Enabling Interoperability via A2A
Enhanced by these protocols, Globant Enterprise AI positions itself as the foundational platform for secure, scalable, and collaborative AI development throughout... Read more.
TSSB Case Against Billionico and Auratus Dismissed as Judge Rebukes TSSB’s Overreach in Securities Case
Administrative Law Judge Rebukes State Regulator for Overreach in Case Targeting Global Education Platform & Digital Gold Vault NORTH BETHESDA, Md., July 31,... Read more.
AeroClave Delivers Breakthrough Biosecurity Operation at Tinker AFB with JBADS Lite Decontamination of E-3 Sentry Aircraft
ORLANDO, Fla., July 31, 2025 /PRNewswire/ — AeroClave LLC, a recognized leader in biodefense and biosecurity solutions, announced the successful completion... Read more.
MATSON, INC. ANNOUNCES SECOND QUARTER 2025 RESULTS
2Q25 EPS of $2.92 versus $3.31 in 2Q24 2Q25 Net Income of $94.7 million versus $113.2 million in 2Q24 2Q25 Consolidated Operating income of $113.0 million versus... Read more.
KLA CORPORATION REPORTS FISCAL 2025 FOURTH QUARTER AND FULL YEAR RESULTS
For the quarter, total revenues were $3.175 billion, towards the upper end of the guidance range; GAAP diluted EPS was $9.06, at the upper end of the guidance range,... Read more.
Trevi Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 7, 2025
Conference call and webcast to be held at 4:30 p.m. ET NEW HAVEN, Conn., July 31, 2025 /PRNewswire/ — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage... Read more.
Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology
BURLINGTON, Mass., July 31, 2025 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered a collaboration with Frenova, a division... Read more.
Rocket Companies Announces Second Quarter 2025 Results
Generated Q2’25 total revenue, net of $1.36 billion and adjusted revenue of $1.34 billion. Adjusted revenue came in above the high end of our guidance range... Read more.
ICF Reports Second Quarter 2025 Results
―Second Quarter in Line with Expectations Led by 27% Revenue Growth in Commercial Energy― ―Margins Continue to Benefit From Favorable Mix― ―Maintains Full... Read more.
AMGEN ANNOUNCES WEBCAST OF 2025 SECOND QUARTER FINANCIAL RESULTS
THOUSAND OAKS, Calif., July 31, 2025 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that it will report its second quarter 2025 financial results on Tuesday,... Read more.